Authors:
BULLER D
MODIANO MR
DEZAPIEN JG
MEISTER J
SALTZMAN S
HUNSAKER F
Citation: D. Buller et al., PREDICTORS OF CERVICAL-CANCER SCREENING IN MEXICAN-AMERICAN WOMEN OF REPRODUCTIVE AGE, Journal of health care for the poor and underserved, 9(1), 1998, pp. 76-95
Authors:
PENDERGRASS KB
MODIANO MR
OTSUKA A
RIZVI N
CHERNOFF SB
Citation: Kb. Pendergrass et al., DOLASETRON (DOL) TABLETS ARE HIGHLY EFFECTIVE IN PREVENTING HIGH-DOSECISPLATIN-INDUCED EMESIS, Annals of oncology, 9, 1998, pp. 691-691
Authors:
RUBENSTEIN EB
GRALLA RJ
HAINSWORTH JD
HESKETH PJ
GROTE TH
MODIANO MR
KHOJASTEH A
KALMAN LA
BENEDICT CR
HAHNE WF
Citation: Eb. Rubenstein et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE TRIAL ACROSS 4 ORAL DOSES OF DOLASETRON FOR THE PREVENTION OF ACUTE EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1216-1224
Authors:
MODIANO MR
VILLARWERSTLER P
CROWLEY J
SALMON SE
Citation: Mr. Modiano et al., EVALUATION OF RACE AS A PROGNOSTIC FACTOR IN MULTIPLE-MYELOMA - AN ANCILLARY OF SOUTHWEST-ONCOLOGY-GROUP STUDY 8229, Journal of clinical oncology, 14(3), 1996, pp. 974-977
Authors:
YEILDING A
BERTOLI L
EISENBERG P
PLEZIA P
MODIANO MR
ALBERTS DS
KHOJASTEH A
CRAMER MB
HAHNE WF
Citation: A. Yeilding et al., ANTIEMETIC EFFICACY OF 2 DIFFERENT SINGLE INTRAVENOUS DOSES OF DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN-CONTAINING CHEMOTHERAPY, American journal of clinical oncology, 19(6), 1996, pp. 619-623